Company** | Location | Technologies | Products/Disease Focus | Development Stage |
Aeterna Labor- | Ste-Foy, | Angiogenesis | Psoriasis | Phase II |
atories Inc. | Quebec | Lung cancer | Phase I | |
(TSE:AEL) | ||||
Allelix Bio- | Mississauga, | Protein therapeutics; | Osteoporosis | Phase II |
pharmaceuticals | Ontario | neuropharmaceuticals | Migraine | Phase I |
Inc. (TSE:AXB) | Gastrointestinal disorders | Phase I | ||
AnorMED Inc.* | Vancouver, | Metal-based therapeutics | Radiopharmaceuticals | Phase III |
British | Cancer therapies | Phase I | ||
Columbia | ||||
Bioniche Inc. | London; | Immunostimulation; | Bladder cancer | Phase III |
(TSE:BNE) | Ontario | hyaluronic acid | ||
Cangene Corp. | Winnipeg, | Plasma products (hyper- | AIDS | Phase II |
(TSE:CNJ) | Manitoba | immune); recombinant | GM-CSF | Phase III |
therapeutics | Oral iron chelator | Phase III | ||
GlycoDesign Inc.* | Toronto, | Glycoprotein-based | Renal cell carcinoma | Phase II |
Ontario | therapeutics | Colorectal cancer | Phase II | |
Hemosol Inc. | Etobicoke, | Human therapeutics | Blood substitute | Phase II |
(TSE:HML) | Ontario | |||
IBEX Technologies | Montreal, | Neutralase for | Cardiovascular disease | Phase III |
Inc. (TSE:IBT) | Quebec | heparin reversal | ||
Inex Technologies | Vancouver, | Lipid-based drug | Chemotherapy | Phase II |
Inc. (TSE:IEX) | British | delivery system | Gene therapy/antisense | Pre-clinical |
Columbia | ||||
Nortran Pharma- | Vancouver, | Small molecule thera- | Anesthesia | Phase II |
ceuticals Inc. | British | peutics for cardio- | Antiarrhythmia | Phase I |
(VSE:NRT) | Columbia | vascular drugs; pain | ||
management | ||||
QLT Photo- | Vancouver, | Photodynamic therapy | Lung and esophageal | On market |
Therapeutics Inc. | British | cancers | ||
(TSE:QLT) | Columbia | |||
Synsorb Biotech | Calgary, | Carbohydrate-based | Hemolytic uremic | Phase III |
Inc. (TSE:SYB) | Alberta | gastroenteric products | syndrome | |
Vasogen Inc. | Toronto, | Patient-specific cell | Peripheral vascular | Approved |
(ME:VAS) | Ontario | therapies | disease | (Europe) |
NOTES: | ||||
ME = Montreal Exchange; TSE = Toronto Stock Exchange; VSE= Vancouver Stock Exchange | ||||
* Private companies are indicated with an asterisk. |